Inhibited anabolic effect of insulin-like growth factor-I on stromal bone marrow cells in endothelial nitric oxide synthase-knockout mice

Acta Physiologica Scandinavica

Volumn 182, Issue 1, 2004, Pages 29-35

  Lagumdzija, A ^a   Ou, G ^a   Petersson, M ^a   Bucht, E ^a   Gonon, A ^a   Pernow, Y ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Endothelial NOS; Human osteosarcoma cells; Insulin like growth factor I; Parathyroid hormone; Parathyroid hormone related protein; Stromal bone marrow cells

Indexed keywords

ALKALINE PHOSPHATASE; NITRIC OXIDE SYNTHASE; OSTEOCALCIN; PARATHYROID HORMONE; PARATHYROID HORMONE RELATED PROTEIN; SOMATOMEDIN C; THYMIDINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; BONE MARROW CELL; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; ENDOTHELIUM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOSARCOMA CELL; PHENOTYPE; PRIORITY JOURNAL; STROMA CELL; WILD TYPE;

ANIMALS; BONE MARROW CELLS; CELL DIVISION; CELL LINE, TUMOR; CELLS, CULTURED; DNA; ENZYME INHIBITORS; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; MICE, KNOCKOUT; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; OSTEOBLASTS; OSTEOCALCIN; PARATHYROID HORMONE; PARATHYROID HORMONE-RELATED PROTEIN; PENICILLAMINE;

EID: 4544258519     PISSN: 00016772     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-201X.2004.01303.x     Document Type: Article

References (24)

1. Afzal, F., Nohadani, M., Huang, P.L., Polak, J.M. & Buttery, L.D.K. 2002. Endothelial nitric oxide synthase is an important regulator of osteoblast growth and differentiation. J Bone Mineral Res 17(Suppl. 1), S149.
2. Aguirre, J., Buttery, L., O'Shaughnessy, M.C. et al. 2001. Endothelial nitric oxide synthase gene-deficient mice demonstrate marked retardation in postnatal bone formation, reduced bone volume and defects in osteoblast maturation and activity. Am J Pathol 158, 247-257.
3. Armour, K.E. & Ralston, S.H. 1998. Estrogen upregulates endothelial constitutive nitric oxide synthase expression in human osteoblast-like cells. Endocrinology 139, 799-802.
4. Armour, K.E., Armour, K.J., Gallagher, M.E. et al. 2001. Defective bone formation and anabolic response to exogenous estrogen in mice with targeted disruption of endothelial nitric oxide synthase. Endocrinology 142, 760-766.
5. Canalis, E. 1980. Effects of insulin-like growth factor on DNA and protein synthesis in cultured rat calvaria. J Clin Invest 66, 707-719.
6. Canalis, E. 1993. Insulin-like growth factors and local regulation of bone formation. Bone 14, 273-276.
7. Centrella, M., McCarthy, T.L. & Canalis, E. 1990. Receptors for insulin-like growth factors-I and -II in osteoblast-enriched cultures from fetal rat bone. Endocrinology 126, 39-44.
8. Ebeling, P.R., Jones, J.D., O'Fallon, W.M., Janes, C.H. & Riggs, B.L. 1993. Short-term effects of recombinant human insulin-like growth factor I on bone turnover in normal women. J Clin Endocrinol Metab 77, 1384-1387.
9. Ghiron, L.J., Thomson, J.L., Holloway, L. et al. 1995. Effects of rhIGF-I and GH on bone turnover in elderly women. J Bone Mineral Res 10, 1844-1852.
10. Kalinowski, L., Dobrucki, L.W. & Malinski, T. 2001. Nitric oxide as a second messenger in parathyroid hormone-related protein signaling. J Endocrinol 170, 433-440.
11. Miao, D., He, B., Tong, X.K., Goltzman, D. & Karaplis, A.C. 2002. Conditional knockout of PTHrP in osteoblasts leads to premature osteoporosis. J Bone Mineral Res 17 (Suppl. 1), S138.
12. O'Shaughnessy, M.C., Polak, J.M., Afzal, F. et al. 2000. Nitric oxide mediates 17β-estradiol-stimulated human and rodent osteoblast proliferation and differentiation. Biochem Biophys Res Commun 277, 604-610.
13. Palmer, R.M., Ferrige, A.G. & Moncada, S. 1987. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327, 524-526.
14. Peter, S.J., Liang, C.R., Kim, D.J., Widmer, M.S. & Mikos, A.G. 1998. Osteoblastic phenotype of rat marrow stromal cells cultured in the presence of dexamethasone, β-glycerophosphate, and L-ascorbic acid. J Cell Biochem 71, 55-62.
15. Robinson, L.J., Werenowicz, S., Marton, C.C. & Michael, T. 1994. Isolation and chromosomal localization of the human endothelial nitric oxide synthase (nos3) gene. Genomics 19, 350-357.
16. Shearer, M.J. 2000. Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification. Curr Opin Clin Nutr Metab Care 3, 433-438.
17. Somjen, D., Binderman, I., Schulter, K.D., Wingender, E., Mayer, H. & Kaye, A.M. 1990. Stimulation by defined parathyroid hormone fragments of cell proliferation in skeletal-derived cell cultures. Biochem J 272, 781-785.
18. Tsai, J.A., Rong, H., Torring, O., Matsushita, H. & Bucht, E. 2000. Interleukin-1β upregulates PTHrP-mRNA expression and protein production and decreases TGF-β in normal human osteoblast-like cells. Calcif Tissue Int 66, 363-369.
19. Tsukahara, H., Gordienko, D.V., Tonshoff, B., Gelato, M.C. & Goligorski, M.S. 1994. Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells. Kidney Int 45, 598-604.
20. Turner, C.H., Owan, L., Jacob, D.S., McClintock, R. & Peacock, M. 1997. Effects of nitric oxide synthase inhibitors on bone formation in rats. Bone 21, 487-490.
21. Van't Hof, R.J. & Ralston, S.H. 2001. Nitric oxide and bone. Immunology 103, 225-261.
22. Walsh, C.A., Bowler, W.B., Bilbe, G., Fraser, W.D. & Gallagher, J.A. 1997. Effects of PTH on PTHrP gene expression in human osteoblasts: up-regulation with the kinetics of an immediate early gene. Biochem Biophys Res Comm 239, 155-159.
23. Wergedal, J.E., Mohan, S., Lundy, M. & Baylink, D.J. 1990. Skeletal growth factor and other growth factors known to be present in bone matrix stimulate proliferation and protein synthesis in human bone cells. J Bone Miner Res 5, 179-186.
24. Zeng, G. & Quon, M.J. 1996. Insulin-stimulated production of nitric oxide is inhibited by wortmannin: direct measurement in vascular endothelial cells. J Clin Invest 98, 894-898.